News About: Pharm. Industry
Korean biopharmaceutical companies urged to boost revenue
The founder and chief executive officer of Celltrion, Seo Jung-jin, made a surprising announcement last Tuesday stating that he would offload his 97.3 percent controlling stake in the company. He said he plans to sell...
Korean biopharmaceutical companies face dismal outlook
In the early 2000s, Korea was basking in the biotechnology boom thanks largely to advanced stem cell research. Strong government support led many research centers to open up bio-related facilities including cord blood...
Doctors, drugmakers call for broader scope of marketing activities
Doctors and pharmaceutical companies have recently called on the government to revise regulations relating to the system that they called ”ambiguous“ in distinguishing between legal and illegal marketing acts.
In a...
Celltrion shares keep fluctuating
Celltrion shares have been still fluctuating after Chairman Seo Jung-jin’s surprise announcement about selling his controlling stake in a biosimilar drugs company to a multinational firm.
Its stock fell on Thursday...
Celltrion CEO to sell entire stake to multinational firm
Celltrion chairman Seo Jung-jin said Tuesday he will sell his entire controlling stake in the firm to a multinational pharmaceutical company to protect the firm from short-selling by speculative investors.
“Company...
Celltrion chairman’s sell-out plan boosts stock price
Celltrion chairman Seo Jung-jin announces Tuesday his plan to sell all of his stakes in the Kosdaq’s No. 1 market cap company and its affiliates to a multinational pharmaceutical company, citing predatory short-sellin...
Hanmi Pharmaceutical credit rating upgraded
Hanmi Pharmaceutical, one of the nation’s leading pharmaceutical companies, said Tuesday it has received an upgrade in its credit rating from A (negative) to A0 (stable) from Korea Ratings (KR) and Korea Investors Ser...
Dismal report for drug makers in 2012
The government’s forced price cuts for drugs and other medical products covered by National Health Insurance in April of last year has dealt a blow to local pharmaceutical firms.
According to Yakup.com, a pharmaceu...
Multinational drug manufactures spend 1.37 trillion won on marketing
The nation’s 26 multinational drug firms spent 1.37 trillion won on marketing activities in 2012, down 3.2 percent from a year earlier, according to documents obtained by Yakup.com, a pharmaceutical information portal...
Mudipharma Korea names new Commercial Excellence DirectorMundipharma Korea announced Monday that Ryu Joon-soo will lead the newly established Commercial Excellence Team of Seoul-based drug manufacturer as a senior management director ...
|
